N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-2-(furan-2-yl)-1H-imidazo[4,5-c]pyridin-4-amine

ID: ALA4527301

PubChem CID: 155544349

Max Phase: Preclinical

Molecular Formula: C23H16ClFN4O2

Molecular Weight: 434.86

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Fc1cccc(COc2ccc(Nc3nccc4[nH]c(-c5ccco5)nc34)cc2Cl)c1

Standard InChI:  InChI=1S/C23H16ClFN4O2/c24-17-12-16(6-7-19(17)31-13-14-3-1-4-15(25)11-14)27-23-21-18(8-9-26-23)28-22(29-21)20-5-2-10-30-20/h1-12H,13H2,(H,26,27)(H,28,29)

Standard InChI Key:  NSNAENYGIMVJTA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   35.7952  -17.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5048  -16.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5020  -15.9357    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7934  -15.5305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0871  -16.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0884  -15.9423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3122  -15.6888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8312  -16.3487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3102  -17.0099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0109  -16.3502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5315  -15.6884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7539  -15.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7528  -16.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5296  -17.0106    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.7896  -14.7133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4954  -14.3014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2029  -14.7116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9082  -14.3004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9049  -13.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1903  -13.0772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4879  -13.4907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1837  -12.2600    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   38.6101  -13.0695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.3203  -13.4739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0255  -13.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7331  -13.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4379  -13.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4335  -12.2367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7184  -11.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0166  -12.2470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7107  -11.0154    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
  8 10  1  0
  4 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 20 22  1  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 29 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4527301

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 434.86

Molecular Weight (Monoisotopic): 434.0946

AlogP: 6.33

#Rotatable Bonds: 6

Polar Surface Area: 75.97

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.05

CX Basic pKa: 6.01

CX LogP: 5.47

CX LogD: 5.38

Aromatic Rings: 5

Heavy Atoms: 31

QED Weighted: 0.33

Np Likeness Score: -1.75

References

1. Gavriil ES, Doukatas A, Karampelas T, Myrianthopoulos V, Dimitrakis S, Mikros E, Marakos P, Tamvakopoulos C, Pouli N..  (2019)  Design, synthesis and biological evaluation of novel substituted purine isosters as EGFR kinase inhibitors, with promising pharmacokinetic profile and in vivo efficacy.,  176  [PMID:31125894] [10.1016/j.ejmech.2019.05.029]

Source

Source(1):

• Scientific Literature